Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.89 HKD
Change Today +0.10 / 5.59%
Volume 19.8M
1011 On Other Exchanges
Symbol
Exchange
Berlin
As of 4:01 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for china nt pharma group co ltd (1011)

Year over year, China NT Pharma Group Company Limited has been able to grow revenues from CNY754.1M CNY to CNY864.6M CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold, SGA expenses and income tax expenses. These changes allowed the company to report positive net income, improving from a loss of CNY673.5M CNY to a profit of CNY2.1M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
Restated
CNY
Dec 31
2012
CNY
Dec 31
2013
CNY
Dec 31
2014
Press
Release

CNY
4 Year
Trend
Revenues2,758.1739.1754.1864.6
TOTAL REVENUES2,758.1739.1754.1864.6
Cost of Goods Sold1,867.5467.3465.1473.3
GROSS PROFIT890.6271.8289.0391.3
Selling General & Admin Expenses, Total581.9709.1467.0317.0
Other Operating Expenses-35.5-2.3-3.3-0.7
OTHER OPERATING EXPENSES, TOTAL546.4706.8463.7316.3
OPERATING INCOME344.3-435.0-174.875.0
Interest Expense-50.0-52.2-70.3-78.0
Interest and Investment Income3.46.422.021.1
NET INTEREST EXPENSE-46.6-45.8-48.4-57.0
Currency Exchange Gains (Loss)18.1-10.9-0.5--
Other Non-Operating Income (Expenses)-8.1-7.9-6.6-0.7
EBT, EXCLUDING UNUSUAL ITEMS307.7-499.5-230.217.3
Merger & Restructuring Charges---676.7-406.1--
Gain (Loss) on Sale of Assets-0.2-1.0-16.6--
EBT, INCLUDING UNUSUAL ITEMS307.5-1,177.3-652.817.3
Income Tax Expense73.1-68.020.615.2
Earnings from Continuing Operations234.4-1,109.3-673.52.1
NET INCOME234.4-1,109.3-673.52.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS234.4-1,109.3-673.52.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS234.4-1,109.3-673.52.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1011:HK $1.89 HKD +0.10

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings 100.0x
Price/Sales 1.9x
Price/Book 7.7x
Price/Cash Flow 941.1x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NT PHARMA GROUP CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.